HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Recent trial news: giradestrant plus everolimus
Hamilton discusses the EVEROS press release, questions about intent‑to‑treat benefit and everolimus tolerability.
Play episode from 28:29
Transcript
